Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein.

EMBO J. 1996 Feb 15;15(4):873-87. Unique Identifier : AIDSLINE MED/96181365
Yamaoka S; Inoue H; Sakurai M; Sugiyama T; Hazama M; Yamada T; Hatanaka M; Department of Viral Oncology, Institute for Virus Research, Kyoto; University, Japan.


Abstract: Human T-cell leukemia virus type I (HTLV-I) encodes a 40 kDa trans-acting protein, Tax, that regulates transcription of both the proviral and cellular genes, and can transform rat fibroblasts. To determine the functional importance of its trans-acting capacities in cell transformation, we have examined two representative pathways of transcriptional activation--HTLV-I long terminal repeat (LTR) mediated and NF-kappa B dependent--by mutational analysis of Tax. In contrast to a previous report, mutants lacking the ability to activate an NF-kappaB-dependent promoter failed to transform rat fibroblasts, whereas a mutation which abolishes the HTLV-I LTR-mediated trans-activation demonstrated a wild-type capacity for cell transformation. Stable expression of Tax competent for transformation caused enhanced DNA binding of NF-kappa B in rat fibroblasts. We also demonstrate that stable co-expression of the NFKB2 precursor, known as a member of the I kappa B proteins, with wild-type Tax blocked transformation as well as eliminated aberrant NF-kappaB activation by Tax without interference with the HTLV-I LTR-mediated trans-activation. Our results indicate that constitutive activation of NF-kappa B is essential for Tax-mediated transformation of rat fibroblasts.
Keywords: Amino Acid Sequence Animal Base Sequence Cell Line *Cell Transformation, Neoplastic DNA-Binding Proteins/METABOLISM Gene Products, tax/*PHYSIOLOGY *Genes, pX Human Molecular Sequence Data NF-kappa B/*METABOLISM Oligonucleotide Probes/CHEMISTRY Point Mutation Rats Structure-Activity Relationship Support, Non-U.S. Gov't Trans-Activation (Genetics) JOURNAL ARTICLEKWDaminoacidsequenceanimalbasesequencecelllineKWDcelltransformation,neoplasticdna-bindingproteins/metabolismgeneproducts,tax/KWDphysiologyKWDgenes,pxhumanmolecularsequencedatanf-kappab/KWDmetabolismoligonucleotideprobes/chemistrypointmutationratsstructure-activityrelationshipsupport,non-uKWDsKWDgov'ttrans-activation(genetics)journalarticle
960930
M9690918

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .